Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesPrognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer
Cancer, 10/26/09
Wang XS et al. – An increased risk for shorter survival was indicated by moderate to severe coughing at baseline or by increased fatigue or shortness of breath during the first chemotherapy cycle in patients with advanced NSCLC. Although cross-validation is needed, these data suggest that an individual patient's symptom severity scores, quickly obtainable in the clinic, might contribute clinically useful information for treatment planning for that patient.
Methods- 94 patients with advanced NSCLC and an Eastern Cooperative Oncology Group performance status (PS) of 0 to 2
- Patients who qualified for chemotherapy rated symptom severity using M. D. Anderson Symptom Inventory before and after their first chemotherapy cycle
- Prognostic values of baseline symptoms and changes in symptom severity examined by Cox proportional hazards models
- In multivariate analysis, controlled for demographic and other factors, baseline coughing rated ≥ 4 independently predicted significantly higher risk for shorter survival
- Patients with coughing ≥ 4 and a PS of 2 were more likely to have shorter survival than patients with coughing < 4 and a PS of 0 to 1
- 1-point or greater increase in severity of fatigue , shortness of breath, or poor appetite from baseline to end of first chemotherapy cycle was also found independently associated with higher risk for poor survival
Xin Shelley Wang, MD, MPH , 10/28/09
| This report strengthens the evidence that symptom report predicts survival, especially in advanced disease, and suggests that symptom assessment should be a part of routine cancer care and research in these patients. |
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Choroidal metastases from lung adenocarcinoma
Clinical and Translational Oncology, 11/25/09
Detection of Chemerin and It’s Clinical Significance in Peripheral Blood of Patients with Lung Cancer
Chinese Journal of Lung Cancer, 11/25/09
Incidence of bacteraemia following endobronchial ultrasound-guided transbronchial needle aspiration
European Respiratory Journal , 11/25/09
Sponsor
Article Search
Sponsor